PTGS2 and osteosarcoma: In addition, zoledronic acid treatment significantly increased PTGS2 protein levels, whereas adding exogenous CoQ10 blocked the zoledronic acid-induced increase in PTGS2 levels in osteosarcoma cells (Figure 4D).